‘Refer to Japan’s half-price policy for generic's price'

By Lee, Tak-Sun | translator Kim, Jung-Ju

23.07.11 12:03:24

가나다라 0

NHIS-affiliated research institution introduces Japan’s aggressive price reduction measure

The price of first generics is lower in Japan, and discounted to 40% from the 10th entrant

Should refer to the price adjustment policy in Japan, and investigate and reflect the actual transaction price in Korea as well”

The Health Insurance Research Institute, a research institution under the National Health Insurance Service, stressed the need to refer to Japan’s generic drug price reduction policies in its recently published ‘Issue & View June 2023.’

Hyun-Ok Lee, Associate Research Fellow of the Health Insurance Research Institute, and her fellow researchers published an article containing the need above in the June issue of Issue & View under the title of 'Recent Changes in Japan's Drug Pricing System and Implications'.

The authors argued that it is necessary to refer to and reflect on Japan’s generic drug pricing system in the paper’s conclusion and implications.

The research team

Lee, Tak-Sun(hooggasi2@dailypharm.com)

If you want to see the full article, please JOIN US (click)